triazoles has been researched along with Liver Failure in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (80.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, H; Gao, SY; Hu, W; Jiang, QL; Li, WJ; Lu, Y; Wang, XX; Wu, DF; Yang, K | 1 |
| Berg, T; Brandmaier, P; Jonas, S; Lübbert, C; Mohr, FW; Pfeiffer, D; Rodloff, A; Schmelzle, M; Schubert, S; Wiltberger, G | 1 |
| Aarnoutse, RE; Blijlevens, NM; Brüggemann, RJ; Burger, DM; Donnelly, JP; Mouton, JW; Verweij, PE; Warris, A | 1 |
| Deschênes, M; Dion, B; Tzimas, GN | 1 |
| Hilhorst, MI; Kuijpers, TW; Scherpbier, HJ | 1 |
| Eloubeidi, MA; Gaede, JT; Swaim, MW | 1 |
| Baretton, G; Schirren, CA | 1 |
| Schwetz, BA | 1 |
1 review(s) available for triazoles and Liver Failure
| Article | Year |
|---|---|
Therapeutic drug monitoring of voriconazole.
Topics: Aging; Antifungal Agents; Drug Interactions; Drug Monitoring; Female; Genotype; Humans; Liver Failure; Male; Pyrimidines; Renal Insufficiency; Sex Characteristics; Triazoles; Voriconazole | 2008 |
9 other study(ies) available for triazoles and Liver Failure
| Article | Year |
|---|---|
Voriconazole-induced severe skin allergy and neurological adverse event in a liver failure patient: A case report.
Topics: Adult; Antifungal Agents; Humans; Hypersensitivity; Liver Failure; Male; Triazoles; Voriconazole | 2022 |
Invasive cardiac aspergillosis after orthotopic liver transplantation.
Topics: Acute Disease; Caspofungin; Drug Therapy, Combination; Echinocandins; Echocardiography, Transesophageal; Hepatitis B; Humans; Lipopeptides; Liver Failure; Liver Transplantation; Lung; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Myocardium; Opportunistic Infections; Postoperative Complications; Pulmonary Aspergillosis; Triazoles | 2014 |
Nefazodone and liver damage.
Topics: Antidepressive Agents, Second-Generation; Humans; Liver; Liver Failure; Piperazines; Triazoles; United States | 2002 |
Early onset, nefazodone-induced fulminant hepatic failure.
Topics: Antidepressive Agents, Second-Generation; Female; Humans; Liver Failure; Male; Middle Aged; Piperazines; Time Factors; Triazoles | 2003 |
Liver failure in a child receiving highly active antiretroviral therapy and voriconazole.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; Child; Fatal Outcome; Female; Humans; Infectious Disease Transmission, Vertical; Liver Failure; Pyrimidines; Triazoles; Voriconazole | 2003 |
Reversible nefazodone-induced liver failure.
Topics: Antidepressive Agents, Second-Generation; Biopsy; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Female; Humans; Liver; Liver Cirrhosis, Alcoholic; Liver Failure; Middle Aged; Piperazines; Triazoles | 2000 |
Nefazodone-induced acute liver failure.
Topics: Acute Disease; Antidepressive Agents, Second-Generation; Humans; Liver Failure; Male; Middle Aged; Piperazines; Triazoles | 2000 |
From the Food and Drug Administration.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Second-Generation; Antineoplastic Agents; Arthritis, Psoriatic; Benzamides; Chemical and Drug Induced Liver Injury; Cyclohexanones; Enzyme Inhibitors; Etanercept; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Immunoglobulin G; Infant; Liver Failure; Nitrobenzoates; Orphan Drug Production; Piperazines; Pyrimidines; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Triazoles; Tyrosinemias; United States; United States Food and Drug Administration | 2002 |
Serzone. Beware of dangerous liver problems.
Topics: Antidepressive Agents, Second-Generation; Contraindications; Drug Labeling; Humans; Liver Failure; Piperazines; Triazoles | 2002 |